The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
General Updates | The standard of care in multiple myeloma & emerging treatment options
Denis O’Keeffe, MD, University Hospital Limerick, Limerick, Ireland, outlines current and emerging treatment options for multiple myeloma. Dr O’Keeffe explains that quadruplet-based induction therapy combined with autologous transplantation is likely to become the standard of care (SOC) in young and fit patients. In addition, Dr O’Keeffe also shares his excitement for upcoming data on novel bispecific antibodies and CAR-T therapies. This interview was recorded virtually.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
